Displaying items by tag: division of pulmonary allergy and critical care medicine
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
Tagged under
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Tagged under
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.
Tagged under
Exacerbations of COPD, particularly mild COPD, lead to a decline in lung function in smokers, according to new research from UAB.
Ben Branscomb, a pioneering physician and long-time UAB faculty member, was often called the father of pulmonary medicine.
Tagged under
Michelle Harris came to UAB on maximal life support, unsure if she would live after a rare multisystem autoimmune disease attacked her lungs. Now, she will go home with her eyes on upcoming prom and graduation.
Tagged under
UAB launches new clinic for primary ciliary dyskinesia, a rare, inherited respiratory disease.
Tagged under
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
Tagged under
UAB researchers led a team that discovered that a smoking-related condition called expiratory airway collapse — often thought inconsequential — is associated with lung disease.
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD. 
The Cystic Fibrosis Foundation recognizes UAB’s Adult CF Program with Quality Care Award.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
Tagged under
A UAB researchers suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis
An experimental lung-volume-reduction procedure using one-way valves shows promise for a UAB patient.
UAB’s William Bailey honored by his alma mater with a lifetime achievement award for 50 years of exemplary service in medicine.
Tagged under
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
Tagged under
UAB is implanting one-way valves in patients with severe emphysema in an effort to reduce their overall lung volume, which improves lung function.
UAB research identifies enzyme that protects lungs and gills following damage from oil dispersant.
UAB’s annual Pulmonary and Critical Care Update features up-to-date info on lung diseases.
UAB has been selected to join the Pulmonary Fibrosis Foundation Care Center Network.